Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
An Open-Label, Single-Arm, Phase 1/2 Dose-Escalation Trial of Long-Acting Recombinant Human IL-7 (NT-I7, Efineptakin-Alpha) for Idiopathic CD4 Lymphopenia
Background: Idiopathic CD4 lymphopenia (ICL) is a syndrome characterized by low levels of certain immune cells called CD4 T cells. The low CD4 T cells renders…
Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID)NCT05600920
Phase 1
A Phase 1 Evaluation of the Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
Background: People with Idiopathic CD4 lymphopenia (ICL) have lower numbers of a type of white blood cell called CD4 cells. White blood cells fight against in…
Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID)NCT04097561